MLYS

Mineralys Therapeutics, Inc. MLYS

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$2.69B total
Catalys Pacific, LLC
$213.25M0.0%
RA CAPITAL MANAGEMENT, L.P.
$207.55M0.0%
BlackRock, Inc.
$158.83M+31.4%
Samsara BioCapital, LLC
$158.40M0.0%
FMR LLC
$121.73M-7.2%
STATE STREET CORP
$111.74M+41.1%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$106.79MNew
VANGUARD CAPITAL MANAGEMENT LLC
$74.38M+12.3%
Laurion Capital Management LP
$67.62M+12.3%
PRICE T ROWE ASSOCIATES INC /MD/
$61.04M+68.4%
ORBIMED ADVISORS LLC
$56.94M+2.8%
Capital World Investors
$53.90M+401.7%
ARMISTICE CAPITAL, LLC
$46.84M+47.6%
Troluce Capital Advisors LLC
$46.64M+163.9%
FRANKLIN RESOURCES INC
$44.13M-8.4%
Andera Partners
$42.95M0.0%
GEODE CAPITAL MANAGEMENT, LLC
$42.75M+21.8%
SR ONE CAPITAL MANAGEMENT, LP
$42.20M0.0%
BANK OF AMERICA CORP /DE/
$40.62M+36.8%
SPHERA FUNDS MANAGEMENT LTD.
$39.66M+9.7%
GOLDMAN SACHS GROUP INC
$39.36M+85.8%
Pictet Asset Management Holding SA
$38.60M+38.3%
Polar Capital Holdings Plc
$38.33M-5.3%
MILLENNIUM MANAGEMENT LLC
$32.96M+132.6%
Ghisallo Capital Management LLC
$30.35MNew
See all 228 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/MLYS

Earnings Per Share

13fpro.ai/company/MLYS

Loading ratio trend…

MLYS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Mineralys Therapeutics, Inc. (MLYS): stock profile, AI score and financials

Mineralys Therapeutics, Inc. (MLYS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MLYS is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of MLYS by reported 13-F value include Catalys Pacific, RA CAPITAL MANAGEMENT, L.P., BlackRock, based on the most recent SEC filings. MLYS trades on the Nasdaq exchange and files with the SEC under CIK 1933414. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MLYS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Mineralys Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1933414 →